A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


Objectives The behavioral, adaptive and quality of life characteristics of attenuated mucopolysaccharidosis type II (MPS II) have not been well studied. Understanding changes over time in the attenuated phenotype may assist in helping achieve better outcomes in long-term function. This longitudinal study investigates these outcomes in relation to age, somatic disease burden, and IQ. Specifically, somatic disease burden is a major challenge for these patients, even with treatment with enzyme replacement therapy. Methods 15 patients, 10 between ages 6 and < 12 and 5 between ages ≥ 12 and 18, were selected who had at least 2 yearly visits. The occurrence of physical signs, the Physical Symptom Score, and IQ in these two groups was studied as well as the longitudinal association of age with standardized measures of quality of life, adaptive function, and behavioral symptoms as rated by parents and the child's self-report. Slopes by age across and within patients were calculated for these measures. Results All but one child had hearing loss, most had joint contractures and short stature. Somatic disease burden increased with age. IQ, although normal for most, also improved with age in those under 12 years of age. Physical quality of life decreased while psychosocial quality of life increased with age. Although other adaptive skills were in the broad average range, daily living skills were low at baseline relative to normative data and decreased over time. Behavior ratings indicated improvement in attention and hyperactivity over time. No patient had severe psychopathology, but older children reported an increasing sense of inadequacy and low self-esteem on self-report, presumably due to increasing awareness of differences from peers over time. Conclusions Attenuated MPS II patients have increasing somatic disease burden and poor physical quality of life as they develop as well as decreasing self-esteem and sense of adequacy. Psychosocial quality of life, adaptive skills, and attention improve. Recognition of and intervention around these issues will be beneficial to MPS II attenuated patients who have the resources to use such assistance to improve their long-term outcomes.

Original languageEnglish (US)
Pages (from-to)32-39
Number of pages8
JournalMolecular Genetics and Metabolism Reports
StatePublished - Jun 2016

Bibliographical note

Funding Information:
This project was supported in part (K. Rudser) by the National Center for Advancing Translational Sciences, National Institutes of Health , through University of Minnesota—CTSI Grant Number NCATS UL1TR000114 . Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.

Funding Information:
The Lysosomal Disease Network supported this study through “Longitudinal Studies of Brain Structure and Function in the Mucopolysaccharidoses” 2009–2014 (E. Shapiro, P.I.). The Lysosomal Disease Network ( U54NS065768 ) is a part of the National Institutes of Health (NIH) Rare Diseases Clinical Research Network, supported through collaboration between the NIH Office of Rare Diseases Research at the National Center for Advancing Translational Science, the National Institute of Neurological Disorders and Stroke (NINDS), and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH (C. Whitley P.I.).

Publisher Copyright:
© 2016 The Authors.


  • Adaptive functions
  • Attenuated mucopolysaccharidosis type II
  • Behavioral outcomes
  • Quality of life


Dive into the research topics of 'A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II'. Together they form a unique fingerprint.

Cite this